Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Completed 18Unknown 14Recruiting 13Terminated 9Not yet recruiting 4Withdrawn 3Suspended 2Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Sarcoma 1Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 122Carboplatin 120Drug Therapy 104Bevacizumab 101Capecitabine 96Oxaliplatin 95Radiotherapy 92Gemcitabine 88Paclitaxel 87tislelizumab 84Cyclophosphamide 83Specimen Handling 80pembrolizumab 76toripalimab 66Magnetic Resonance Spectroscopy 63Fluorouracil 61sintilimab 58Injections 57anlotinib 51Docetaxel 51Surgical Procedures, Operative 48130-nm albumin-bound paclitaxel 48fludarabine 45Pemetrexed 43Standard of Care 42Biopsy 42venetoclax 41Irinotecan 41lenvatinib 40Leucovorin 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Propranolol × Clear all
NCT07583134 2026-05-15

B-BIT

Seoul St. Mary's Hospital

Phase 4 Not yet recruiting
100 enrolled
Breast

Breast Neoplasms

NCT07549906 2026-04-24

Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study

Sun Yat-sen University

Phase 2 Not yet recruiting
45 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05741164 2026-02-17

Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer

Emory University

Phase 2 Not yet recruiting
37 enrolled
Breast

Triple Negative Breast Neoplasms

NCT05797662 2026-01-23

A Study of Propranolol to Treat Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Not yet recruiting
25 enrolled
Sarcoma

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡